Mercado mundial de vacunas para uso veterinario: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de vacunas para uso veterinario

Los crecientes brotes de enfermedades del ganado y el aumento de la población de ganado son factores importantes para la enorme aceptación de las vacunas para rumiantes, en particular para el ganado vacuno. La incidencia de la mayoría de las enfermedades del ganado se debe en parte a la falta de experiencia de los veterinarios en el diagnóstico y la notificación de la enfermedad. La producción de vacunas está aumentando rápidamente.

Data Bridge Market Research analiza que el mercado de vacunas veterinarias para animales, que fue de USD 10.69 mil millones en 2022, aumentaría a USD 18.23 mil millones para 2030 y se espera que experimente una CAGR del 6,9% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de vacunas para uso veterinario

Market Definition

Veterinary-animal vaccines prevent several livestock diseases from spreading, protecting animal and human health. Food, milk, meat, protein, and other commercial items such as leather and wool derive from animals. Rabies vaccinations, foot and mouth disease vaccines, and equine influenza virus vaccines are among the most widely used veterinary vaccines, which prevent the transfer of infectious pathogens by simulating naturally acquired immunity.

Global Veterinary-Animal Vaccines Market Dynamics

Drivers

• Increasing Research Activities Associated with Veterinary-animal vaccines

An increasing number of research activities have been done for the betterment of the market growth. For instance, the U.K. announced the establishment a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, aiming to increase vaccine development for livestock and control the spread of viral diseases. The U.K. government will contribute USD 24.79 million, whereas the Bill & Melinda Gates Foundation will contribute USD 19.43 million to launch this center. Thus, the research initiatives adopted by several market players and huge government support will expand the market growth. This factor leads to the growth of the market.

• Increasing Demand for Attenuated Live Vaccines

The attenuated live vaccines have recently led to huge market growth. Live attenuation is the most traditional vaccination method used in the veterinary field. This method is also under trial for the development of added applications. Some of these options include the development of protein subunit vaccines for swine, which are given intramuscularly. These products help decrease the mortality rate and enhance the life span of disease-affected swine. Thus, this factor help in the market growth.

Opportunities

• Increasing Demand for Intranasal Administration

The intranasal segment is expected to grow greatly due to its growing popularity. Mostly, intranasal vaccines are limited to a single dose of vaccine. The growing incidence of respiratory diseases in animals and research activities by major market players to develop better vaccines are anticipated to boost the market growth. Thus, this factor boosts market growth.  

• Increasing Strategic Developments Associated with Veterinary-animal vaccines

Various companies are continuously launching veterinary-animal vaccine products, creating many market growth opportunities. For instance, Ceva partnered with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for R&D to prevent several infectious diseases from animal origin and improve animal health in 2021. Furthermore, Zoetis launched the Poulvac Procerta HVT-IBD vaccine to protect poultry against Infectious Bursal Disease (IBD) in 2021. Thus, this factor serves as a major factor that increases market growth.

Restraints/Challenges

• Side-Effects of Veterinary-Animal Vaccines

Several effects are associated with veterinary-animal vaccine products. Local effects such as discomfort and local swelling at the vaccination site, decreased appetite and activity, mild fever, sneezing, a snotty nose, and mild coughing. Thus, this factor impedes market growth.  

This veterinary-animal vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary-animal vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, Boehringer Ingelheim India launched a single-shot poultry vaccine, VAXXITEK HVT+IBD. VAXXITEK HVT+IBD is a novel recombinant vaccine that offers life-long protection for all producing chickens, including layer, broiler, and breeder chickens. It protects against two important immunosuppressive diseases such as IBD (Infectious Bursal Disease) and Marek's Disease

Global Veterinary- Animal Vaccines Market Scope

The veterinary-animal vaccines market is segmented on the basis of type, disease, technology, route of administration, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Bovine
• Small Ruminant
• Companion Animal Vaccines
• Canine
• Feline
• Aquaculture Vaccines
• Other Animal Vaccines

Disease

• Porcine
• Poultry
• Livestock
• Bovine
• Small Ruminant
• Companion Animals
• Canine
• Feline
• Aquaculture

Technology

• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Other Vaccines

Route of Administration

• Oral
• Parenteral
• Topical

End Use

• Hospitals
• Clinics

Veterinary- Animal Vaccines Market Regional Analysis/Insights

The veterinary-animal vaccines market is analyzed and market size insights and trends are provided by type, disease, technology, route of administration, and end use as referenced above.

The countries covered in the veterinary-animal vaccines market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to grow during the forecast period veterinary-animal vaccines market due to the increasing occurrences of livestock and zoonotic diseases, resulting in many animal deaths in this region. Furthermore, improvement in animal health expenditure and the wide presence of renowned pharmaceutical companies will increase this region's market's growth rate.

Asia-Pacific dominates the market in the forecast period because of the rising livestock population in this region. The increase in the livestock population and government initiatives, particularly in emerging economies, are some of the main factors anticipated to surge the market growth in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The veterinary-animal vaccines market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for veterinary-animal vaccines market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the veterinary-animal vaccines market. The data is available for historic period 2011-2021.

Competitive Landscape and Veterinary- Animal Vaccines Market Share Analysis

El panorama competitivo del mercado de vacunas veterinarias para animales proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de vacunas veterinarias para animales.

Algunos de los principales actores que operan en el mercado de vacunas veterinarias para animales son:

• Bayer AG (Alemania)
• Sanofi (Francia)
• Pfizer Inc. (Estados Unidos)
• GSK plc (Reino Unido)
• Merck & Co., Inc. (Estados Unidos)
• Ceva (Francia)
• Cargill, Incorporated (Estados Unidos)
• Boehringer Ingelheim International GmbH (Alemania)
• Takeda Pharmaceutical Company Limited (Japón)
• Zoetis (Estados Unidos)
• Dechra Pharmaceuticals PLC (Reino Unido)
• Hester Biosciences Limited (India)
• Elanco (Estados Unidos)
• Corporación de Salud Animal Phibro (Estados Unidos)
• Indovax (India)

SKU-12324